Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Sequential VAD and VTD Followed by HDT With ASCT and Velcade Maintenance for NDMM

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2006 by Korean Multiple Myeloma Working Party.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Janssen-Cilag Ltd.
Information provided by:
Korean Multiple Myeloma Working Party
ClinicalTrials.gov Identifier:
NCT00378755
First received: September 20, 2006
Last updated: September 21, 2006
Last verified: September 2006
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2008
  Estimated Primary Completion Date: No date given